Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Despite rapid advances during the past two decades there are still unanswered questions
There have been numerous advances during the past two decades in the treatment of birthmarks, concerning both efficacy and safety. Although initial results of laser treatment for portwine stains are encouraging, there remain unanswered questions about the long term benefits. The response of other birthmarks to laser therapy is variable, and much work still remains to be done.
Laser treatment has become the standard of care for the management of portwine stains. The past two decades have witnessed the progression of these devices from crude, non-selective forms of treatment to highly sophisticated lasers capable of selective photothermolysis. In spite of this, the results of treatment leave much to be desired. Although the vast majority of portwine stains lighten significantly with treatment, only 15–20% clear completely.1 Moreover, a recent disturbing report revealed what many of us had suspected for some time: portwine stains can recur after treatment.1 The implications of this are yet to be determined. These findings lead to several important questions: why are we not able to clear more lesions and have there been any recent developments to improve our results?
Two of the most important considerations are the depth of the vessels and their diameter. For some time, we have known that there is a significant variation in the depth of the vessels in portwine stains. Given the limited depth of penetration of yellow light (1–2 mm at 585 nm), our inability to effectively treat the full thickness of some of the lesions seemed inevitable. Recent work has shown that there is indeed a correlation between the depth of the vessels and the response to laser treatment.2 In lesions where the mean depth of the vessels is greater than 1030 μm, the response was poor, whereas lesions with much more superficial vessels (mean vessel depth of less than 830 μm) responded well. In a separate study, the response to treatment also depended on the vessel depth.3
There are two ways to increase the depth of penetration of light. The first and most obvious is to increase the wavelength of light from the standard 585 nm to 595 nm or even 600 nm. The second is to increase the spot size from 5 mm to 7.5 mm and even 10 mm. Based on Monte Carlo modelling, the larger the spot size (up to 1 cm), the greater the degree of scatter and the deeper the effective treatment depth.4
The diameter of the vessels also seems to play a critical role in whether or not the lesion will respond to treatment. Dierickx et al showed that pulsewidths in the millisecond domain would be more appropriate than the standard 500 μs pulse width available on most pulsed dye lasers.5 This was based on the calculated thermal relaxation times of the vessels that make up these lesions. Therefore, in order to improve our ability to treat larger vessels, the pulse width needed to be increased from 500 μs to the millisecond range.
The next advance came in the form of surface cooling. Nelson et al showed that cooling the skin surface with a cryogen spray just prior to the delivery of the laser pulse will accomplish two major advantages.6 Firstly, the likelihood of epidermal damage is reduced; and secondly, the pain of treatment is diminished. A third advantage in the form of greater efficacy soon became evident. Epidermal cooling enabled us to increase the fluence without the risk of epidermal damage.7 An increase in fluence translates into a more effective treatment and most importantly, a greater effect on the deeper vessels. This important advance led to surface cooling becoming a standard feature of pulsed dye lasers.
Several other methods of cooling soon became available. These included contact methods in which a cooled surface is placed against the skin during treatment, and non-contact methods in which a cold stream of air is directed at the surface during treatment.6,7 At this point, there are no clinical data comparing these methods. Anecdotal reports suggest that all are effective and there does not appear to be any major difference in efficacy.
Lasers and light sources
Pulsed dye lasers are the most widely used. Since their introduction in the late 1980s, numerous modifications have been made; the most recent features incorporated into these lasers include the following:
Longer wavelengths (585–600 nm). Most physicians treat in the 585–595 nm range. Anecdotal comments suggest that 600 nm appears to be too long and less effective.8
Bigger spot sizes. Most lasers will offer 7 mm and 10 mm options.
Longer pulsewidths. At this time, there are no clinical data to support longer pulsewidths but anecdotal reports favour a 1500 μs exposure times.8 Clinical experience with pulsewidths longer than this has not resulted in improved results.
Surface cooling. Several techniques of cooling are in use. These include cryogen spray, cold air, a cold window, and a cooled sapphire tip. There appear to be advantages and disadvantages of all of these methods but they do not appear to translate into any difference in efficacy. It is, however, most important that we use one of the methods of cooling.
The features mentioned above do appear to improve our results although at this point, good clinical data has not been published. These developments are however, recent, and it is expected that published clinical data will likely follow.
The most recent generation of pulsed dye lasers with all of the above features as well as a pulsewidth in the millisecond domain (up to 50 ms) has become available. There are clear theoretical advantages to the longer millisecond pulsewidth, but whether or not these will translate into better clinical efficacy remains to be seen.
Other devices are also useful. These include KTP lasers and Nd:YAG lasers; more recently a source of non-coherent intense pulsed light has been used with some success.
KTP lasers emit a wavelength of 532 nm (green light) which is as well absorbed by oxyhaemoglobin as light at 585 nm, but unfortunately there is greater absorption by melanin and more dermal scattering.9 This will limit the depth of penetration. On the other hand, these devices are capable of millisecond exposure times and can be delivered with surface cooling. It was therefore hoped that they would be useful to treat grade IV (c.f.) lesions. They have in fact been used successfully to treat all grades of portwine stain, but their use is not as widespread as pulsed dye lasers and to date, no published data attests to their efficacy. Nd:YAG lasers have very limited use and are unsafe in inexperienced hands. They can be used to treat cobblestones only.10
Sources of intense pulsed light with appropriate filtering and surface cooling are also useful for treating all grades of portwine stain but once again, their use is not as widespread as pulsed dye lasers.11 In skilled hands, these devices are beneficial.
PATHOGENESIS AND CLASSIFICATION
Evidence suggests that portwine stains are the result of a segmental, absolute, or relative deficiency in autonomic innervation of the post-capillary venules in the papillary dermis.12–14 This results in a progressive dilatation of the venules of the lesion throughout the life of the patient. An absolute deficiency in autonomic innervation will result in a more rapid progression with early hypertrophy and cobblestone formation. A relative deficiency results in a slower progress of the lesion. Since vessel diameter is such an important factor, a classification based on vessel size would seem logical. Such a classification exists and has both a clinical and a pathological basis. It is helpful in selecting a treatment modality.14
Grade I lesions: vessel diameters are in the 80 μm range. These lesions are light pink macules.
Grade II lesions: vessel diameters measure up to 120 μm. These lesions are darker pink macules.
Grade III lesions: vessel diameters measure up to 150 μm. These lesions are red macules.
Grade IV lesions: vessel diameters are greater than 150 μm. These lesions are purple and may become papular.
Since laser treatment destroys ectatic vessels which are the consequence of a deficient autonomic innervation, laser treatment will only impact the effect and not the cause of a portwine stain. It therefore stands to reason that many, if not all, will recur since the autonomic deficiency seems to be segmental and is likely to affect all of the vessels, both large and small, in the affected area.
A clinical approach
Pulsed dye lasers are the most widely used lasers in this field. Their efficacy with grade IV lesions and lesions with cobblestone formation is poor, probably because of the fact that the vessels that make up these lesions have diameters that require millisecond exposure times. Although the addition of surface cooling and higher fluences may well change this, at this point, KTP lasers and intense pulsed light sources are useful for grade IV lesions.11 In the presence of cobblestone formation, Nd:YAG lasers are useful, but if the cobblestones have been present for several years, surgical excision may be necessary.10 Surgical correction of soft tissue hypertrophy is occasionally helpful, especially with lip and eyelid hypertrophy.10 Surgical excision and full thickness skin grafting is, however, no longer warranted and given the success of laser treatment, this should be strongly discouraged.
Pulsed dye lasers are essential to treat the superficial component of a hemangioma during both the proliferative phase of development and the phase of involution. During the proliferative phase, it is felt that repetitive treatments administered at 3–4 weekly intervals may diminish the ultimate size of the lesion, and in some cases, even completely resolve the lesion.15 Pulsed dye laser treatment has also been advocated for ulcerated lesions.16 While in most cases this is appropriate, in a very small number of patients, ulceration may in fact worsen after treatment, especially in segmental lesions. Skin resurfacing with both CO2 lasers and Er:YAG lasers is useful for treating the atrophic scarring that so often remains after an ulcerated segmental lesion has involuted.17 Further to this, the newer “combined” lasers that combine the use of more precise ablation with an Er:YAG laser and the effect of collagen shrinkage from a CO2 laser or a long pulsed Er:YAG laser would be, at least theoretically, better.
The newer generation of Q-switched lasers can selectively destroy melanosomes and are thus useful for treating benign lesions, such as café au lait macules, lentigenes, and nevus of Ota.
Café au lait macules
Unfortunately, early reports of success have been tempered by the fact that many eventually recur after treatment.18 In a recent study, lesions with an irregular jagged edge had the most favourable response to treatment.19
Nevus of Ota
The results of treatment with Q-switched ruby lasers have been disappointing.22 All appear to eventually recur.
Despite rapid advances during the past two decades there are still unanswered questions